Matches in Nanopublications for { ?s ?p "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP687074.RAQMQE8h2IZOu0HgtAHHEWrr4MkDGlGBOLAHe9GiUbqso130_assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687074.RAQMQE8h2IZOu0HgtAHHEWrr4MkDGlGBOLAHe9GiUbqso130_provenance.
- assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1108522.RAa6D-5DJjHjBPE3-L0T9ODoygRdE6zEoqi3Mp8HPAwu8130_assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108522.RAa6D-5DJjHjBPE3-L0T9ODoygRdE6zEoqi3Mp8HPAwu8130_provenance.
- NP541196.RAs55ukFYN6vmOtAmZd6JeXJWq5tbeuT8r5um7LSYWSOI130_assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541196.RAs55ukFYN6vmOtAmZd6JeXJWq5tbeuT8r5um7LSYWSOI130_provenance.
- NP1108517.RApl-bEndOYweiSM2L9ELV3WAguewLF2WZlElPcrVVZS0130_assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108517.RApl-bEndOYweiSM2L9ELV3WAguewLF2WZlElPcrVVZS0130_provenance.
- NP541284.RAOdxKqYFjsJdXan6RVfw2Bq6XghBTSmpyVziEOPdHSAs130_assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541284.RAOdxKqYFjsJdXan6RVfw2Bq6XghBTSmpyVziEOPdHSAs130_provenance.
- NP687093.RANoyMD-15xQoIURri_czVEOT8vqlbzoBm74IMnC5BtX8130_assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687093.RANoyMD-15xQoIURri_czVEOT8vqlbzoBm74IMnC5BtX8130_provenance.
- NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_provenance.
- NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108526.RA7zaD1pVY0b6TzXQvtj8pqFSSaBJ36AODeACaZ7OlEYg130_provenance.